Israel’s PolyPid Revives $80 Million NASDAQ IPO Plan

Israel’s PolyPid, which develops an antibiotic coating for bone repair, is reinitiating plans for an IPO. It hopes to raise $18 – $22 million for a company valuation of as much as $80 million. After More...